Global injectible drug delivery devices market to hit $317.2b by 2029

Biologic drug development is driving the demand for advanced injectable delivery systems.

The global injectible drug delivery devices market is projected to reach $317.2b by 2029 at a compound annual growth rate of 7.9%, said BCC Research LLC.

The sector’s expansion is attributed to the rising cases of diabetes, cancer, and other chronic conditions, along with a growing elderly population.

“Self-injecting devices are becoming increasingly popular, offering ease of use and better treatment adherence,” the report said.

Meanwhile, the development of biologic drugs has driven the demand for advanced injectable delivery systems designed to handle sensitive formulations.

Technological developments such as wearable injectors and smart delivery systems are improving the efficiency and convenience of drug administration, contributing to market growth.